Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03003897 · ClinicalTrials.gov registry record
Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.
A clinical trial, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- 609
- Enrollment target
NCT03003897: Completed study, sponsored by University of Illinois at Urbana-Champaign.
NCT03003897 is a clinical trial that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 609 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03003897 has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- 609 participants
- Enrollment target
Study Summary
Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in overweight and obese individuals. The investigators will evaluate results of randomized controlled trials (RCTs) of soluble fiber supplementation among overweight and obese adults for outcomes related to weight management (e.g. body mass index \[BMI\], body weight, body fat percentage, waist circumference) and glucose and insulin homeostasis (e.g. fasting glucose, homeostasis model assessment of insulin resistance \[HOMA-IR\], fasting insulin) through systematic review and meta-analysis.
Interventions
- OTHER Placebo
- OTHER Soluble Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 609 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-10 |
What the finished NCT03003897 record still lists
NCT03003897 is an observational study that tracks outcomes without assigning an intervention. The registered 609 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03003897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03003897 about?
NCT03003897 is a clinical study titled "Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.". Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in over...
What is the current status of trial NCT03003897?
This trial is currently completed. The enrollment target is 609 participants. The study started on 2016-01. Estimated completion is 2017-10.
What interventions are being tested in trial NCT03003897?
The interventions under investigation include: Placebo (OTHER), Soluble Fiber (OTHER).
Who is sponsoring clinical trial NCT03003897?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- NCT05838638 · 610 participants · NA
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
- NCT07075718 · 610 participants · Phase 2
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia